Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
US Department of Justice
UBS
Dow
Covington
Chubb
QuintilesIMS
Argus Health
Teva

Generated: August 19, 2018

DrugPatentWatch Database Preview

Ortho Mcneil Pharm Company Profile

« Back to Dashboard

What is the competitive landscape for ORTHO MCNEIL PHARM, and what generic and branded alternatives to ORTHO MCNEIL PHARM drugs are available?

ORTHO MCNEIL PHARM has twenty-nine approved drugs.



Summary for Ortho Mcneil Pharm
US Patents:0
Tradenames:32
Ingredients:17
NDAs:29

Drugs and US Patents for Ortho Mcneil Pharm

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ortho Mcneil Pharm ORTHO-NOVUM 7/14-28 ethinyl estradiol; norethindrone TABLET;ORAL-28 019004-002 Apr 4, 1984 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Ortho Mcneil Pharm TYCOLET acetaminophen; hydrocodone bitartrate TABLET;ORAL 089385-001 Aug 27, 1986 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Ortho Mcneil Pharm CLISTIN carbinoxamine maleate TABLET;ORAL 008915-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial
Ortho Mcneil Pharm ESTRADIOL estradiol FILM, EXTENDED RELEASE;TRANSDERMAL 021048-002 Sep 20, 1999 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Ortho Mcneil Pharm FLOXIN ofloxacin INJECTABLE;INJECTION 020087-002 Mar 31, 1992 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Ortho Mcneil Pharm TYLENOL W/ CODEINE acetaminophen; codeine phosphate TABLET;ORAL 085056-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Ortho Mcneil Pharm

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ortho Mcneil Pharm FLOXIN ofloxacin INJECTABLE;INJECTION 020087-002 Mar 31, 1992 4,382,892 ➤ Try a Free Trial
Ortho Mcneil Pharm FLOXIN IN DEXTROSE 5% ofloxacin INJECTABLE;INJECTION 020087-001 Mar 31, 1992 4,382,892 ➤ Try a Free Trial
Ortho Mcneil Pharm FLOXIN ofloxacin INJECTABLE;INJECTION 020087-003 Mar 31, 1992 4,382,892 ➤ Try a Free Trial
Ortho Mcneil Pharm FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER ofloxacin INJECTABLE;INJECTION 020087-004 Mar 31, 1992 4,382,892 ➤ Try a Free Trial
Ortho Mcneil Pharm FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER ofloxacin INJECTABLE;INJECTION 020087-005 Mar 31, 1992 4,382,892 ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Merck
Moodys
Cerilliant
Cantor Fitzgerald
Express Scripts
Federal Trade Commission
Mallinckrodt
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.